TY - JOUR
T1 - High-performance liquid chromatographic separation of renin-angiotensin system peptides and most of their metabolic fragments
AU - Pelegrini-da-Silva, Adriana
AU - Prado, Wiliam A.
AU - Juliano, Maria A.
AU - Wilk, Sherwin
AU - Martins, Antonio R.
N1 - Funding Information:
We thank Dr. M. Orlowski, Mount Sinai School of Medicine, NY, USA, and Dr. M. Hitchens, Merck-Sharp and Dohme Research, Piscataway, NJ, USA, for the generous gifts of cf-Ala-Ala-Phe-pAB, and lisinopril, respectively. We acknowledge the skilful technical assistance of Mr. Hildeberto Caldo and Mr. Afonso P. Padovan. Amino acid analysis were carried out by the Protein Chemistry Laboratory of Faculty of Medicine of Ribeirão Preto. This work was supported by CNPq, FAEPA and FAPESP.
PY - 2002/11/25
Y1 - 2002/11/25
N2 - We describe here a gradient HPLC procedure for the separation, and quantification by UV absorption of renin tri- and tetradecapeptide substrates, angiotensins I, II, III, IV and V, angiotensin-derived peptides, and peptidase inhibitors including amastatin, bestatin, pepstatin, lisinopril, a renin peptide inhibitor, Z-Pro-prolinal, N-[1-(R, S)-carboxy-2-phenylethyl]-L-Ala-L-Ala-L-Phe-p-aminobenzoate, and phosphoramidon. Most peptides and peptidase inhibitors were baseline-resolved within 32 min. The overall intra- and inter-assay precisions ranged from 0.8 to 5.9 (n=6) and 2 to 13% (n=6), respectively. There was a linear relationship (correlation coefficients≥0.9660) between peak height and peptide amount injected. In conclusion, the present method when combined with a peptidase-inhibitor paradigm can lead to the identification of renin-angiotensin system metabolizing enzymes, and when combined with radioimmunoassay can enhance the specificity of angiotensin measurement.
AB - We describe here a gradient HPLC procedure for the separation, and quantification by UV absorption of renin tri- and tetradecapeptide substrates, angiotensins I, II, III, IV and V, angiotensin-derived peptides, and peptidase inhibitors including amastatin, bestatin, pepstatin, lisinopril, a renin peptide inhibitor, Z-Pro-prolinal, N-[1-(R, S)-carboxy-2-phenylethyl]-L-Ala-L-Ala-L-Phe-p-aminobenzoate, and phosphoramidon. Most peptides and peptidase inhibitors were baseline-resolved within 32 min. The overall intra- and inter-assay precisions ranged from 0.8 to 5.9 (n=6) and 2 to 13% (n=6), respectively. There was a linear relationship (correlation coefficients≥0.9660) between peak height and peptide amount injected. In conclusion, the present method when combined with a peptidase-inhibitor paradigm can lead to the identification of renin-angiotensin system metabolizing enzymes, and when combined with radioimmunoassay can enhance the specificity of angiotensin measurement.
KW - Peptides
KW - Renin-angiotensin
UR - http://www.scopus.com/inward/record.url?scp=0037175430&partnerID=8YFLogxK
U2 - 10.1016/S1570-0232(02)00542-1
DO - 10.1016/S1570-0232(02)00542-1
M3 - Article
C2 - 12401356
AN - SCOPUS:0037175430
SN - 1570-0232
VL - 780
SP - 301
EP - 307
JO - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
JF - Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences
IS - 2
ER -